What the Next Five Years Could Look Like for Smoking & Vaping in Australia
Australia’s battle against tobacco and e‑cigarettes is far from over. Recent data show 1.8 million adults still smoke daily and the number of vapers has tripled since 2019. While legislation tightened in 2021, emerging trends suggest new challenges and opportunities for health‑care professionals, especially those working in eye care.
Rise of Dual Use: A Growing Public‑Health Puzzle
Surveys from 2024 indicate that up to 25 % of current smokers also vape on a weekly basis. Dual users tend to consume more nicotine overall, which amplifies the risk of both age‑related macular degeneration (AMD) and dry eye disease. A 2023 case study from a Melbourne optometry clinic found that dual users were twice as likely to present with early signs of cataract compared with exclusive smokers.
Regulatory Ripples: How New Policies May Shape Behaviour
Australia’s 2024 amendment to the Therapeutic Goods Act restricts nicotine‑containing vapes to prescription‑only status. Early modeling predicts a 15 % decline in youth vaping by 2027, provided enforcement is consistent. However, experts warn that a black‑market surge could offset gains, especially in regional areas where access to Quitline is already limited.
Eye Health Professionals as Front‑Line Cessation Champions
Every optometrist visit is a teachable moment. The RANZCO brief‑advice model recommends the “Ask‑Advise‑Help” (AAH) framework, a three‑step conversation that takes under two minutes.
Real‑world impact is clear: In a pilot program across three Victorian eye clinics, patients who received AAH plus an automatic Quitline referral were 34 % more likely to call the service within 30 days compared with those who only received verbal advice.
Technology‑Driven Support: Apps, Tele‑health, and AI
By 2026, we expect AI‑powered chatbots to handle initial nicotine‑dependence screening, freeing clinicians to focus on personalised counselling. One Australian startup, SmokeFreeAI, reports a 22 % increase in quit attempts after integrating its chatbot into optometry practice management software.
Future‑Proofing Your Practice
- **Track smoking status** in electronic health records – a simple “yes/no” field can trigger automatic referral workflows.
- **Partner with local Quitline**: Use the online referral form to submit consented details instantly.
- **Educate on ocular risks**: Highlight that each extra pack‑year raises AMD risk by 6 % (source: Kulkarni & Banait, 2023).
- **Offer nicotine‑replacement therapy (NRT)** samples or vouchers through your pharmacy network.
FAQ – Quick Answers for Patients & Practitioners
- Is vaping safer for my eyes than smoking?
- Current evidence shows vaping still poses risks – including dry‑eye disease and possible ocular burns from device failure. It is not a “safe” alternative.
- How many times can I use the AAH model in one appointment?
- You can apply it once per visit. Re‑visit the conversation at follow‑up appointments to reinforce motivation.
- Can I get free cessation support?
- Yes. Quitline offers free, confidential counselling and can arrange NRT or prescription medications through your GP.
- Do Aboriginal and Torres Strait Islander patients need a different approach?
- Brief, culturally‑sensitive advice works well. Dedicated Aboriginal Quitline services provide tailored support and interpreters.
- What’s the best way to document nicotine dependence?
- Record the type (cigarette, vape, dual), frequency, and any previous quit attempts in the patient’s chart.
Take Action Today
Ready to make a difference in your patients’ eye health and overall wellbeing? Contact our team for a free AAH training kit, download the latest Smoking Cessation Guide, and share your success stories in the comments below. Together we can turn every eye exam into a step toward a smoke‑free Australia.
